999999 Participants Needed

Genetic Studies for Cancer

Recruiting at 43 trial locations
SG
Overseen ByStephen Gruber
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: City of Hope Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how genetic and behavioral factors might influence cancer development and progression. Participants will provide samples, such as blood or saliva, and complete questionnaires to help researchers understand these connections. The trial seeks individuals who have had cancer or have family members with a history suggesting a genetic link, such as early cancer diagnoses or rare tumor types in the family.

As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new insights and advancements in cancer prevention and treatment.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on genetic and behavioral factors, so it's best to ask the trial coordinators for specific guidance.

Why are researchers excited about this trial?

Researchers are excited about the molecular genetics study because it could uncover how genetic factors contribute to cancer development. Unlike current treatments that directly target tumors, this study focuses on collecting biological samples like blood, saliva, and tissue from patients and their relatives. These samples could reveal genetic patterns that help predict cancer risk and guide personalized prevention and treatment strategies. This approach aims to move beyond traditional methods, potentially leading to more precise and effective interventions in the future.

Who Is on the Research Team?

SG

Stephen Gruber, MD

Principal Investigator

City of Hope Medical Center

Are You a Good Fit for This Trial?

Inclusion Criteria

Young age cancer diagnosis
Multiple primary neoplasms in affected member
The presence of rare tumor types in the family
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Biospecimen Collection

Participants provide samples of blood, saliva, eyebrow plucks, urine, and/or stored tumor or healthy tissue

Follow-up

Participants are monitored for genetic and behavioral factors affecting cancer outcomes

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Biospecimen Collection
  • Questionnaire Administration
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Ancillary-correlative (biospecimen collection)Experimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

City of Hope Medical Center

Lead Sponsor

Trials
614
Recruited
1,924,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security